(Q79285506)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Plasma osteopontin levels are associated with the presence and extent of coronary artery disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

Cardiology and cardiovascular medicine

21 December 2019

main subject

coronary artery disease

1 reference

based on heuristic

inferred from title

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)00298-3

31 March 2024

author name string

Reiko Ohmori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Yukihiko Momiyama

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Hiroaki Taniguchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Rie Takahashi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Masatoshi Kusuhara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Haruo Nakamura

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Fumitaka Ohsuzu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14612215

31 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 December 2019

https://api.elsevier.com/content/article/PII:S0021915003002983?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)00298-3

https://api.elsevier.com/content/article/PII:S0021915003002983?httpAccept=text/plain

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)00298-3

31 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

333-337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

Macromolecules in bone matrix

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Expression of osteopontin in calcified coronary atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

NK-104, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Molecular and cellular biology of osteopontin Potential role in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Osteopontin and beta 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Changes in osteopontin mRNA expression during phenotypic transition of rabbit arterial smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

DNA microarray profiling to identify angiotensin-responsive genes in vascular smooth muscle cells: potential mediators of vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Osteopontin plays an important role in the development of medial thickening and neointimal formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Development of atherosclerosis in osteopontin transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E–Deficient Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

High coronary artery calcium scores pose an extremely elevated risk for hard events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900298-3

Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue

7 January 2021

23

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)00298-3

Soluble osteopontin and vascular calcification in hemodialysis patients

31 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(03)00298-3

31 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14612215%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference